GM1 Gangliosidosis-A Mini-Review.
Nicoli ER, Annunziata I, d'Azzo A, Platt FM, Tifft CJ, Stepien KM.
Front Genet. 2021 Sep 3;12:734878. doi: 10.3389/fgene.2021.734878. eCollection 2021.
Ovine GM-1 gangliosidosis.
Prieur DJ, Ahern-Rindell AJ, Murnane RD.
Am J Pathol. 1991 Dec;139(6):1511-3.
Type-II GM-1 gangliosidosis?
Kint JA, Dacremont G, Vlietinck R.
Lancet. 1969 Jul 12;2(7611):108-9. doi: 10.1016/s0140-6736(69)92420-9.
Telemedicine and GM-2 gangliosidosis (Tay-Sachs) disease - A new savior on the horizon during COVID-19 pandemic.
Grover R, Sutar S, Juneja S.
Indian J Ophthalmol. 2021 Jul;69(7):1955. doi: 10.4103/ijo.IJO_681_21.
Deficiency of the frontotemporal dementia gene GRN results in gangliosidosis.
Boland S, Swarup S, Ambaw YA, Malia PC, Richards RC, Fischer AW, Singh S, Aggarwal G, Spina S, Nana AL, Grinberg LT, Seeley WW, Surma MA, Klose C, Paulo JA, Nguyen AD, Harper JW, Walther TC, Farese RV Jr.
Nat Commun. 2022 Oct 7;13(1):5924. doi: 10.1038/s41467-022-33500-9.
Late-onset Tay-Sachs disease.
Barritt AW, Anderson SJ, Leigh PN, Ridha BH.
Pract Neurol. 2017 Oct;17(5):396-399. doi: 10.1136/practneurol-2017-001665. Epub 2017 Jul 24.
GM-1 gangliosidosis in a cat.
Blakemore WF.
J Comp Pathol. 1972 Apr;82(2):179-85. doi: 10.1016/0021-9975(72)90061-8.
Sialidase NEU3 action on GM1 ganglioside is neuroprotective in GM1 gangliosidosis.
Allende ML, Lee YT, Byrnes C, Li C, Tuymetova G, Bakir JY, Nicoli ER, James VK, Brodbelt JS, Tifft CJ, Proia RL.
J Lipid Res. 2023 Dec;64(12):100463. doi: 10.1016/j.jlr.2023.100463. Epub 2023 Oct 21.
[GM1 gangliosidosis--case report].
Obradović S, Laban O, Igrutinović Z, Vuletić B, Vujić A, Dindić J.
Med Pregl. 2010 May-Jun;63(5-6):427-30. doi: 10.2298/mpns1006427o.
GM1 gangliosidosis: review of clinical, molecular, and therapeutic aspects.
Brunetti-Pierri N, Scaglia F.
Mol Genet Metab. 2008 Aug;94(4):391-396. doi: 10.1016/j.ymgme.2008.04.012. Epub 2008 Jun 3.
